Moderna is testing arguably it's most important level, where we found more price interaction. The price has been compressing and now we can expect an important movement in the short term.
What would it be?
Hopefully this dies ... And doesnt wake up ever again.
Or someone can call another pandemic and then vaccines are about to be taken again right? say 2025?
Informed Players and speculators at Sub $100 levels are booking gains
we wait for additional drwadowns and re accomodation ACCUMULATION of designated Bankers for the next run up OR cycle
Vaccine COViD was intense HiV was the sell on News..
we await next Drama and Biden Policy on Healthcare etc..
for now Watch or Chrun at key leves (eyeball the box)
This strategy dissects the dual nature of big pharmaceutical firms like Johnson & Johnson, Pfizer, Moderna, and Merck & Co viewed through base Fibonacci Extension Clustering. Despite big pharma's significant contributions to healthcare, these firms have benefited from questionable practices, including price manipulation and exploiting addictions . Price...
support zone become resistance zone also context is looking good for short selling
price is below weekly and monthly VWAP
m30 chart show bearish engulfing to confirm entry
so this level is OK to short
I plan a short trade ( NASDAQ:MRNA ) at 144.41. The entry is just before the resistance zone at ~145.50 which is also confirmed by the Fibonacci 0.5 level. At 146.69 is the stop loss placed so that there is enough space to breathe. The take profit is very conservatively placed at a risk-reward ratio of 1:1.
MRNA descended this past winter off a head-and-shoulders pattern on the daily chart just under
the demand zone as shown by the LuxAlgo indicator. Price is now in a downtrend heading into
earnings tomorrow. MRNA needs to show something good otherwise it will break through the
demand zone and keep going down.
This is a risky earnings play betting that...
Part 1:
The136.50 target was hit and Moderna is now resting at a critical neckline area which bulls have defended for quite some time. I expect a small bounce here but ultimately, a break of this level and a spill much lower. View of the weekly chart below:
This is a head and shoulders within a head & shoulders playing out. It would be invalidated if MRNA can...
I will be looking for a short tomorrow on any bounce.
Bearish marubozo daily candle with a rejection of the 200DMA, cutting through the 50DMA(green) then 20DMA(yellow) like butter and on monster volume. Not good! High probability of downside continuation tomorrow & the 20 + 50 DMAs will now flip from support to resistance.
Downside price target: Major area of...
MRNA has been in a bearish trend from quite a while but now it has started to move back up
Its following a very good resistance trend retest . The recent drop was due to bad news but it should be back on track soon
According to FIB after crossing 176 the bullish reversal will be confirmed
Entry @ 176
SL 170
TP after 202+
MRNA is not looking too good.
What we can see is a weekly bearish engulfing candle after clear rejection from the upsloping resistance line. Rejection was nasty therefore we're seeing instant follow through.
You can short it now with a final target at the support which is the entry for longs too.
At the support, flip bullish and take a long position. The target...
$MRNA has bottomed recently, and has been trending logically in the daily timeframe, we have a 2nd signal forming here, continuing the uptrend that kicked off on March 13th.
Upside can be substantial given broad market action, so I suggest to get involved with the stock (and likely also $PFE soon) here.
Best of luck!
Cheers,
Ivan Labrie.
The price is moving into a range which was already tested in 2021.
Possible positive price action on the go on this last wave. But it may be too early to say it.
SPY - I had no real bias going into today's session other than mentioning last night that downside was more likely to come today because of the failed 2U daily created on monday. We closed slightly red after seeing a decent drop to the high 393 area, forming a weak bearish 2D. Going into wednesday (3/29), I am hoping to see some downward continuation to the...
